Take a look at our comments to the U.S. Patent & Trademark Office on the Patent Trial and Appeal Board (PTAB) rules! These rules impact the affordability of medications by addressing invalid pharmaceutical patents, which can drive up drug prices for patients like us!
Key Points:
Empowerment in Healthcare: Our comments emphasize the importance of patient voices in healthcare policy, advocating for regulations that support lower drug prices by challenging invalid patents.
Support for Proposed Regulations: We support regulations that prioritize the merits of petitions and preserve the ability for any individual to file a review, which can lead to significant reductions in drug costs.
Impact on Public Health: We feel the proposed changes aim to balance public interest and maintain accessible PTAB proceedings, which we believe to be crucial for innovation and competition in the pharmaceutical industry.
Read more to gain insight into how these changes could enhance healthcare access and quality for young adult patients with chronic conditions!